Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse.

Fabio SerpentiMariarita SciumèGiulia GalassiGiorgia SaporitiFederica GrifoniNicolò RampiFrancesca CavallaroKordelia BarbullushiElena TagliaferriMaria GoldanigaLuca BaldiniNicola Stefano FracchiollaFrancesco Onida

Published in: Leukemia & lymphoma (2022)

Keyphrases

acute myeloid leukemia
stem cells
stem cell transplantation
bone marrow
allogeneic hematopoietic stem cell transplantation
chronic lymphocytic leukemia
hematopoietic stem cell
free survival
high dose
low dose